111 related articles for article (PubMed ID: 27899803)
1. Novel targets in the treatment of chronic graft-versus-host disease.
Im A; Hakim FT; Pavletic SZ
Leukemia; 2017 Mar; 31(3):543-554. PubMed ID: 27899803
[TBL] [Abstract][Full Text] [Related]
2. New Approaches for the Treatment of Chronic Graft-Versus-Host Disease: Current Status and Future Directions.
Saidu NEB; Bonini C; Dickinson A; Grce M; Inngjerdingen M; Koehl U; Toubert A; Zeiser R; Galimberti S
Front Immunol; 2020; 11():578314. PubMed ID: 33162993
[TBL] [Abstract][Full Text] [Related]
3. Janus Kinase Inhibitors and Cell Therapy.
Assal A; Mapara MY
Front Immunol; 2021; 12():740847. PubMed ID: 34531878
[TBL] [Abstract][Full Text] [Related]
4. Current Advances in Graft-versus-host Disease After Intestinal Transplantation.
Oza K; Kang J; Patil D; Owen KL; Cui W; Khan K; Kaufman SS; Kroemer A
Transplantation; 2024 Feb; 108(2):399-408. PubMed ID: 37309025
[TBL] [Abstract][Full Text] [Related]
5. Updates in chronic graft-versus-host disease.
Hamilton BK
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):648-654. PubMed ID: 34889364
[TBL] [Abstract][Full Text] [Related]
6. The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.
Cooke KR; Luznik L; Sarantopoulos S; Hakim FT; Jagasia M; Fowler DH; van den Brink MRM; Hansen JA; Parkman R; Miklos DB; Martin PJ; Paczesny S; Vogelsang G; Pavletic S; Ritz J; Schultz KR; Blazar BR
Biol Blood Marrow Transplant; 2017 Feb; 23(2):211-234. PubMed ID: 27713092
[TBL] [Abstract][Full Text] [Related]
7. CD24Fc to DAMPen GVHD.
Martin PJ
Blood; 2024 Jan; 143(1):1-2. PubMed ID: 38175676
[No Abstract] [Full Text] [Related]
8. New and emerging therapies for acute and chronic graft
Hill L; Alousi A; Kebriaei P; Mehta R; Rezvani K; Shpall E
Ther Adv Hematol; 2018 Jan; 9(1):21-46. PubMed ID: 29317998
[TBL] [Abstract][Full Text] [Related]
9. Acute Graft
Nassereddine S; Rafei H; Elbahesh E; Tabbara I
Anticancer Res; 2017 Apr; 37(4):1547-1555. PubMed ID: 28373413
[TBL] [Abstract][Full Text] [Related]
10. Ibrutinib for chronic graft-versus-host disease after failure of prior therapy.
Miklos D; Cutler CS; Arora M; Waller EK; Jagasia M; Pusic I; Flowers ME; Logan AC; Nakamura R; Blazar BR; Li Y; Chang S; Lal I; Dubovsky J; James DF; Styles L; Jaglowski S
Blood; 2017 Nov; 130(21):2243-2250. PubMed ID: 28924018
[TBL] [Abstract][Full Text] [Related]
11. Rehabilitation in Chronic Graft-Versus-Host Disease.
Smith SR; Asher A
Phys Med Rehabil Clin N Am; 2017 Feb; 28(1):143-151. PubMed ID: 27912993
[TBL] [Abstract][Full Text] [Related]
12. Biology of chronic graft-
Presland RB
World J Transplant; 2016 Dec; 6(4):608-619. PubMed ID: 28058210
[TBL] [Abstract][Full Text] [Related]
13. Ruxolitinib for the treatment of patients with steroid-refractory GVHD: an introduction to the REACH trials.
Jagasia M; Zeiser R; Arbushites M; Delaite P; Gadbaw B; Bubnoff NV
Immunotherapy; 2018 Apr; 10(5):391-402. PubMed ID: 29316837
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets.
Zeiser R; Blazar BR
N Engl J Med; 2017 Dec; 377(26):2565-2579. PubMed ID: 29281578
[No Abstract] [Full Text] [Related]
15. Acute and chronic Graft-versus-host disease after hematopoietic stem cell transplantation.
Funke VA; Moreira MC; Vigorito AC
Rev Assoc Med Bras (1992); 2016 Oct; 62 Suppl 1():44-50. PubMed ID: 27982319
[TBL] [Abstract][Full Text] [Related]
16. The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease.
Staffas A; Burgos da Silva M; van den Brink MR
Blood; 2017 Feb; 129(8):927-933. PubMed ID: 27940475
[TBL] [Abstract][Full Text] [Related]
17. New agents in HSC mobilization.
Domingues MJ; Nilsson SK; Cao B
Int J Hematol; 2017 Feb; 105(2):141-152. PubMed ID: 27905003
[TBL] [Abstract][Full Text] [Related]
18. Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease.
Zeiser R; von Bubnoff N; Butler J; Mohty M; Niederwieser D; Or R; Szer J; Wagner EM; Zuckerman T; Mahuzier B; Xu J; Wilke C; Gandhi KK; Socié G;
N Engl J Med; 2020 May; 382(19):1800-1810. PubMed ID: 32320566
[TBL] [Abstract][Full Text] [Related]
19. Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial.
Jagasia M; Perales MA; Schroeder MA; Ali H; Shah NN; Chen YB; Fazal S; Dawkins FW; Arbushites MC; Tian C; Connelly-Smith L; Howell MD; Khoury HJ
Blood; 2020 May; 135(20):1739-1749. PubMed ID: 32160294
[TBL] [Abstract][Full Text] [Related]
20. Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy.
Zeiser R; Blazar BR
N Engl J Med; 2017 Nov; 377(22):2167-2179. PubMed ID: 29171820
[No Abstract] [Full Text] [Related]
[Next] [New Search]
